The Role of Immunotherapy in the Treatment of Advanced Cervical Cancer: Current Status and Future Perspectives
Cervical cancer remains one of the most common cancers in women around the world however therapeutic options in the advanced and recurrent setting are limited. Immune checkpoint inhibitors (ICI) have been considered an attractive option given the viral etiology of cervical cancer although the majori...
Main Authors: | Robert J. Walsh, David S. P. Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/19/4523 |
Similar Items
-
Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
by: Masahiro Kagabu, et al.
Published: (2020-03-01) -
Immunotherapy in Cervical and Endometrial Cancer: Current Landscape and Future Directions
by: Dimitrios Stefanoudakis, et al.
Published: (2024-03-01) -
The Role of Immunotherapy in a Tolerogenic Environment: Current and Future Perspectives for Hepatocellular Carcinoma
by: Liliana Montella, et al.
Published: (2021-07-01) -
Immunotherapy for Thymomas and Thymic Carcinomas: Current Status and Future Directions
by: Arun Rajan, et al.
Published: (2024-03-01) -
Current Status and Future Perspectives of Immunotherapy for Locally Advanced or Metastatic Urothelial Carcinoma: A Comprehensive Review
by: Tae Jin Kim, et al.
Published: (2020-01-01)